EDGAR Filing Documents for 0001144204-13-063893

Form 8-K - Current report:

SEC Accession No. 0001144204-13-063893

Filing Date

2013-11-25

Accepted

2013-11-25 10:43:39

Documents

Period of Report

2013-11-19

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	v361350_8k.htm	8-K	39934
2	EXHIBIT 4.1	v361350_ex4-1.htm	EX-4.1	644060
3	EXHIBIT 10.1	v361350_ex10-1.htm	EX-10.1	152746
4	EXHIBIT 10.2	v361350_ex10-2.htm	EX-10.2	151586
5	EXHIBIT 10.3	v361350_ex10-3.htm	EX-10.3	192118
6	EXHIBIT 10.4	v361350_ex10-4.htm	EX-10.4	192893
7	GRAPHIC	tlogo.jpg	GRAPHIC	4472
8	GRAPHIC	tpg62.jpg	GRAPHIC	2897
9	GRAPHIC	tpg63.jpg	GRAPHIC	4015
10	GRAPHIC	tpg64.jpg	GRAPHIC	3884
11	GRAPHIC	tpg65.jpg	GRAPHIC	3983
12	GRAPHIC	tpg67.jpg	GRAPHIC	3211
13	GRAPHIC	tpg68.jpg	GRAPHIC	5137
	Complete submission text file	0001144204-13-063893.txt		1413673

Mailing Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154

Business Address 21 CORPORATE CIRCLE P O BOX 15098 ALBANY NY 12203-5154 5184640279

ALBANY MOLECULAR RESEARCH INC (Filer) CIK: 0001065087 (see all company filings)